{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:48:01Z","timestamp":1774493281854,"version":"3.50.1"},"reference-count":41,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Fanconi anemia (FA), a genetic DNA repair disorder characterized by marrow failure and cancer susceptibility. In FA mice, metformin improves blood counts and delays tumor development. We conducted a single institution study of metformin in nondiabetic patients with FA to determine feasibility and tolerability of metformin treatment and to assess for improvement in blood counts. Fourteen of 15 patients with at least 1 cytopenia (hemoglobin &amp;lt; 10 g\/dL; platelet count &amp;lt; 100\u2009000 cells\/\u00b5L; or an absolute neutrophil count &amp;lt; 1000 cells\/\u00b5L) were eligible to receive metformin for 6 months. Median patient age was 9.4 years (range 6.0-26.5 ). Thirteen of 14 subjects (93%) tolerated maximal dosing for age; 1 subject had dose reduction for grade 2 gastrointestinal symptoms. No subjects developed hypoglycemia or metabolic acidosis. No subjects had dose interruptions caused by toxicity, and no grade 3 or higher adverse events attributed to metformin were observed. Hematologic response based on modified Myelodysplastic Syndrome International Working Group criteria was observed in 4 of 13 evaluable patients (30.8%; 90% confidence interval, 11.3-57.3). Median time to response was 84.5 days (range 71-128 days). Responses were noted in neutrophils (n = 3), platelets (n = 1), and red blood cells (n = 1). No subjects met criteria for disease progression or relapse during treatment. Correlative studies explored potential mechanisms of metformin activity in FA. Plasma proteomics showed reduction in inflammatory pathways with metformin. Metformin is safe and tolerable in nondiabetic patients with FA and may provide therapeutic benefit. This trial was registered at as #NCT03398824.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021006490","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T19:52:54Z","timestamp":1651521174000},"page":"3803-3811","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":15,"title":["Metformin for treatment of cytopenias in children and young adults with Fanconi anemia"],"prefix":"10.1182","volume":"6","author":[{"given":"Jessica A.","family":"Pollard","sequence":"first","affiliation":[{"name":"1Pediatric Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA;"},{"name":"2Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"3Department of Pediatrics, Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elissa","family":"Furutani","sequence":"additional","affiliation":[{"name":"1Pediatric Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA;"},{"name":"2Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"3Department of Pediatrics, Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[{"name":"4Biostatistics and Research Design Center, Institutional Centers for Clinical and Translational Research, Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Esrick","sequence":"additional","affiliation":[{"name":"1Pediatric Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA;"},{"name":"3Department of Pediatrics, Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8196-8800","authenticated-orcid":false,"given":"Laurie E.","family":"Cohen","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Harvard Medical School, Boston, MA;"},{"name":"5Department of Endocrinology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2387-5462","authenticated-orcid":false,"given":"Jacob","family":"Bledsoe","sequence":"additional","affiliation":[{"name":"6Department of Pathology, Boston Children\u2019s Hospital, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0823-0252","authenticated-orcid":false,"given":"Chih-Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"7Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Lu","sequence":"additional","affiliation":[{"name":"7Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jose Ramirez","family":"de Haro","sequence":"additional","affiliation":[{"name":"8Joint Research Unit UAB-Sant Pau Biomedical Research Institute,Institut de Recerca Hospital de la Santa Creu i Sant Pau-IIB Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona Spain;"},{"name":"25Center for Biomedical Network Research on Rare Diseases, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Surrall\u00e9s","sequence":"additional","affiliation":[{"name":"8Joint Research Unit UAB-Sant Pau Biomedical Research Institute,Institut de Recerca Hospital de la Santa Creu i Sant Pau-IIB Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona Spain;"},{"name":"25Center for Biomedical Network Research on Rare Diseases, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maggie","family":"Malsch","sequence":"additional","affiliation":[{"name":"1Pediatric Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA;"},{"name":"9Clinical Research Operations Center, Institutional Centers for Clinical and Translational Research, Boston Children\u2019s Hospital, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Kuniholm","sequence":"additional","affiliation":[{"name":"9Clinical Research Operations Center, Institutional Centers for Clinical and Translational Research, Boston Children\u2019s Hospital, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6036-1591","authenticated-orcid":false,"given":"Ashley","family":"Galvin","sequence":"additional","affiliation":[{"name":"9Clinical Research Operations Center, Institutional Centers for Clinical and Translational Research, Boston Children\u2019s Hospital, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Armant","sequence":"additional","affiliation":[{"name":"10Trans Laboratory, Boston Children\u2019s Hospital, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8699-2439","authenticated-orcid":false,"given":"Annette S.","family":"Kim","sequence":"additional","affiliation":[{"name":"11Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlyn","family":"Ballotti","sequence":"additional","affiliation":[{"name":"1Pediatric Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Moreau","sequence":"additional","affiliation":[{"name":"12Comprehensive Center for Fanconi Anemia, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7557-3186","authenticated-orcid":false,"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[{"name":"1Pediatric Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1745-0353","authenticated-orcid":false,"given":"Daria","family":"Babushok","sequence":"additional","affiliation":[{"name":"13Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Boulad","sequence":"additional","affiliation":[{"name":"14Pediatric Hematology-Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clint","family":"Carroll","sequence":"additional","affiliation":[{"name":"15Pediatric Hematology-Oncology, The Children's Hospital at TriStar Centennial, Nashville, TN;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2725-0635","authenticated-orcid":false,"given":"Helge","family":"Hartung","sequence":"additional","affiliation":[{"name":"16Pediatric Hematology-Oncology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Hont","sequence":"additional","affiliation":[{"name":"17Pediatric Hematology-Oncology, Children\u2019s National Medical Center, Washington, DC;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taizo","family":"Nakano","sequence":"additional","affiliation":[{"name":"18Pediatric Hematology-Oncology, Children\u2019s Hospital Colorado, Denver, CO;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Olson","sequence":"additional","affiliation":[{"name":"16Pediatric Hematology-Oncology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sei-Gyung","family":"Sze","sequence":"additional","affiliation":[{"name":"19Department of Pediatrics, Maine Medical Center, Tufts University School of Medicine, Portland, ME;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4961-8103","authenticated-orcid":false,"given":"Alexis A.","family":"Thompson","sequence":"additional","affiliation":[{"name":"20Pediatric Hematology-Oncology, Ann and Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, IL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6638-9643","authenticated-orcid":false,"given":"Marcin W.","family":"Wlodarski","sequence":"additional","affiliation":[{"name":"21Department of Hematology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Gu","sequence":"additional","affiliation":[{"name":"22Beth Israel Deaconess Medical Center Genomics, Proteomics, Bioinformatics and Systems Biology Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4006-8179","authenticated-orcid":false,"given":"Towia A.","family":"Libermann","sequence":"additional","affiliation":[{"name":"22Beth Israel Deaconess Medical Center Genomics, Proteomics, Bioinformatics and Systems Biology Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6168-6294","authenticated-orcid":false,"given":"Alan","family":"D\u2019Andrea","sequence":"additional","affiliation":[{"name":"23Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Grompe","sequence":"additional","affiliation":[{"name":"24Oregon Stem Cell Center, Department of Pediatrics, Pap\u00e9 Family Institute, Oregon Health and Science University, Portland, OR; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edie","family":"Weller","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Harvard Medical School, Boston, MA;"},{"name":"4Biostatistics and Research Design Center, Institutional Centers for Clinical and Translational Research, Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4683-9958","authenticated-orcid":false,"given":"Akiko","family":"Shimamura","sequence":"additional","affiliation":[{"name":"1Pediatric Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA;"},{"name":"2Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"3Department of Pediatrics, Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"issue":"4","key":"2022062715232805900_B1","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","article-title":"A 20-year perspective on the International Fanconi Anemia Registry (IFAR)","volume":"101","author":"Kutler","year":"2003","journal-title":"Blood."},{"issue":"2","key":"2022062715232805900_B2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/blood-2004-01-0083","article-title":"Individualized risks of first adverse events in patients with Fanconi anemia","volume":"104","author":"Rosenberg","year":"2004","journal-title":"Blood."},{"issue":"1","key":"2022062715232805900_B3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/17474086.2016.1268048","article-title":"Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations","volume":"10","author":"Ebens","year":"2017","journal-title":"Expert Rev Hematol."},{"issue":"2","key":"2022062715232805900_B4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bcmd.2011.11.006","article-title":"Treatment of the bone marrow failure in Fanconi anemia patients with danazol","volume":"48","author":"Scheckenbach","year":"2012","journal-title":"Blood Cells Mol Dis."},{"issue":"1","key":"2022062715232805900_B5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/pbc.24617","article-title":"Oxandrolone for the treatment of bone marrow failure in Fanconi anemia","volume":"61","author":"Rose","year":"2014","journal-title":"Pediatr Blood Cancer."},{"issue":"1","key":"2022062715232805900_B6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/08880018.2015.1129567","article-title":"Androgen therapy in Fanconi anemia: a retrospective analysis of 30 years in Germany","volume":"33","author":"Paustian","year":"2016","journal-title":"Pediatr Hematol Oncol."},{"issue":"1","key":"2022062715232805900_B7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1182\/asheducation-2017.1.96","article-title":"Treatment of inherited bone marrow failure syndromes beyond transplantation","volume":"2017","author":"Calado","year":"2017","journal-title":"Hematology (Am Soc Hematol Educ Program)."},{"issue":"3","key":"2022062715232805900_B8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ajh.20183","article-title":"Androgens and liver tumors: Fanconi\u2019s anemia and non-Fanconi\u2019s conditions","volume":"77","author":"Velazquez","year":"2004","journal-title":"Am J Hematol."},{"issue":"5","key":"2022062715232805900_B9","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/bjh.16445","article-title":"Androgen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure Registry","volume":"189","author":"Catal\u00e0","year":"2020","journal-title":"Br J Haematol."},{"issue":"24","key":"2022062715232805900_B10","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1182\/blood-2010-04-278226","article-title":"Fancd2-\/- mice have hematopoietic defects that can be partially corrected by resveratrol","volume":"116","author":"Zhang","year":"2010","journal-title":"Blood."},{"issue":"7324","key":"2022062715232805900_B11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nature09571","article-title":"Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells","volume":"468","author":"Nakada","year":"2010","journal-title":"Nature."},{"issue":"5","key":"2022062715232805900_B12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1615\/CritRevOncog.2014011765","article-title":"The role of the Lkb1\/AMPK pathway in hematopoietic stem cells and leukemia","volume":"19","author":"Saito","year":"2014","journal-title":"Crit Rev Oncog."},{"key":"2022062715232805900_B13","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.tips.2020.09.001","volume":"41","author":"He, L. Metformin","year":"2020","journal-title":"Trends Pharmacol Sci."},{"issue":"3","key":"2022062715232805900_B14","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1124\/jpet.107.124123","article-title":"Evidence for in\u00a0vivo scavenging by aminoguanidine of formaldehyde produced via semicarbazide-sensitive amine oxidase-mediated deamination","volume":"322","author":"Kazachkov","year":"2007","journal-title":"J Pharmacol Exp Ther."},{"issue":"7354","key":"2022062715232805900_B15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature10192","article-title":"Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice","volume":"475","author":"Langevin","year":"2011","journal-title":"Nature."},{"issue":"7417","key":"2022062715232805900_B16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nature11368","article-title":"Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function","volume":"489","author":"Garaycoechea","year":"2012","journal-title":"Nature."},{"issue":"1","key":"2022062715232805900_B17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molcel.2015.08.020","article-title":"Endogenous formaldehyde is a hematopoietic stem cell genotoxin and metabolic carcinogen","volume":"60","author":"Pontel","year":"2015","journal-title":"Mol Cell."},{"issue":"18","key":"2022062715232805900_B18","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2013-06-507962","article-title":"Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients","volume":"122","author":"Hira","year":"2013","journal-title":"Blood."},{"issue":"24","key":"2022062715232805900_B19","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1182\/blood-2015-11-683490","article-title":"Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice","volume":"128","author":"Zhang","year":"2016","journal-title":"Blood."},{"issue":"2","key":"2022062715232805900_B20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/pbc.21589","article-title":"Abnormalities in glucose tolerance are common in children with fanconi anemia and associated with impaired insulin secretion","volume":"51","author":"Elder","year":"2008","journal-title":"Pediatr Blood Cancer."},{"issue":"3","key":"2022062715232805900_B21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1210\/jc.2014-4357","article-title":"Endocrine disorders in Fanconi anemia: recommendations for screening and treatment","volume":"100","author":"Petryk","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022062715232805900_B22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood-2005-10-4149","article-title":"Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia","volume":"108","author":"Cheson","year":"2006","journal-title":"Blood."},{"key":"2022062715232805900_B23","first-page":"87\u20131","article-title":"Diagnosis of Fanconi anemia by diepoxybutane analysis","volume":"85","author":"Auerbach","year":"2015","journal-title":"Curr Protoc Hum Genet."},{"issue":"5","key":"2022062715232805900_B24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/acs.chemrestox.8b00040","article-title":"Accurate measurement of formaldehyde-induced DNA-protein cross-links by high-resolution orbitrap mass spectrometry","volume":"31","author":"Liu","year":"2018","journal-title":"Chem Res Toxicol."},{"issue":"9","key":"2022062715232805900_B25","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jmoldx.2020.06.006","article-title":"Targeted informatics for optimal detection, characterization, and quantification of FLT3 internal tandem duplications across multiple next-generation sequencing platforms","volume":"22","author":"Tsai","year":"2020","journal-title":"J Mol Diagn."},{"issue":"12","key":"2022062715232805900_B26","doi-asserted-by":"crossref","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold","year":"2010","journal-title":"PLoS One."},{"key":"2022062715232805900_B27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-4614-4118-2_20","article-title":"Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics","volume":"735","author":"Mehan","year":"2013","journal-title":"Adv Exp Med Biol."},{"issue":"19","key":"2022062715232805900_B28","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.3109\/14767058.2015.1118044","article-title":"Serum angiogenic profile in abnormal placentation","volume":"29","author":"Biberoglu","year":"2016","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"1","key":"2022062715232805900_B29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/14767058.2016.1275546","article-title":"Relationship between first trimester aneuploidy screening test serum analytes and placenta accreta","volume":"31","author":"B\u00fcke","year":"2018","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"3","key":"2022062715232805900_B30","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/gerona\/glaa326","article-title":"Proteome-wide analysis using SOMAscan identifies and validates chitinase-3-like protein 1 as a risk and disease marker of delirium among older adults undergoing major elective surgery","volume":"77","author":"Vasunilashorn","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"4","key":"2022062715232805900_B31","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/SLA.0000000000003283","article-title":"Identification of plasma proteome signatures associated with surgery using SOMAscan","volume":"273","author":"Fong","year":"2021","journal-title":"Ann Surg."},{"key":"2022062715232805900_B32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.12.008","article-title":"Chromosome fragility in the buccal epithelium in patients with Fanconi anemia","volume":"472","author":"Ram\u00edrez","year":"2020","journal-title":"Cancer Lett."},{"key":"2022062715232805900_B33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mrgentox.2016.09.001","article-title":"The radioprotective effect of metformin against cytotoxicity and genotoxicity induced by ionizing radiation in cultured human blood lymphocytes","volume":"809","author":"Cheki","year":"2016","journal-title":"Mutat Res Genet Toxicol Environ Mutagen."},{"issue":"7","key":"2022062715232805900_B34","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/bmt.2016.32","article-title":"Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors","volume":"51","author":"Anur","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"2022062715232805900_B35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.diabres.2018.05.023","article-title":"Metformin in cancer","volume":"143","author":"Mallik","year":"2018","journal-title":"Diabetes Res Clin Pract."},{"issue":"1","key":"2022062715232805900_B36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","article-title":"Benefits of metformin in attenuating the hallmarks of aging","volume":"32","author":"Kulkarni","year":"2020","journal-title":"Cell Metab."},{"issue":"3","key":"2022062715232805900_B37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tips.2020.01.003","article-title":"Context-dependent pharmacological effects of metformin on the immune system","volume":"41","author":"Marcucci","year":"2020","journal-title":"Trends Pharmacol Sci."},{"issue":"3","key":"2022062715232805900_B38","doi-asserted-by":"crossref","first-page":"e33411","DOI":"10.1371\/journal.pone.0033411","article-title":"Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis","volume":"7","author":"Noto","year":"2012","journal-title":"PLoS One."},{"issue":"3","key":"2022062715232805900_B39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canep.2012.12.009","article-title":"Association of metformin use with cancer incidence and mortality: a meta-analysis","volume":"37","author":"Zhang","year":"2013","journal-title":"Cancer Epidemiol."},{"issue":"1","key":"2022062715232805900_B40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/phar.1334","article-title":"Effects of metformin dose on cancer risk reduction in patients with type 2 diabetes mellitus: a 6-year follow-up study","volume":"34","author":"Lin","year":"2014","journal-title":"Pharmacotherapy."},{"issue":"9","key":"2022062715232805900_B41","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/1940-6207.CAPR-13-0424","article-title":"Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders","volume":"7","author":"Gandini","year":"2014","journal-title":"Cancer Prev Res (Phila)."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/12\/3803\/1904372\/advancesadv2021006490.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/12\/3803\/1904372\/advancesadv2021006490.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T15:24:20Z","timestamp":1656343460000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/12\/3803\/485132\/Metformin-for-treatment-of-cytopenias-in-children"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,6,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021006490","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]}}}